首页> 外国专利> Use of two microRNAs in lung cancer prognosis and drug preparation

Use of two microRNAs in lung cancer prognosis and drug preparation

机译:两种microRNA在肺癌预后和药物制备中的应用

摘要

The present invention relates to use of two microRNAs in detection of lung cancer prognosis and in medicine preparation. Particularly, the invention relates to a composition comprising two small RNA molecules microRNA-150 and microRNA-886-3p, a device comprising the composition used in detection of lung cancer prognosis and in preparation of medicaments for inhibiting mammal and human lung cancer metastasis. Specifically, the expression levels of microRNA-150 and microRNA-886-3p can be used as the prognostic criteria of lung cancer prognosis, wherein high expression level of the gene combination indicates favorable therapeutic effect. The invention also relates to a device detecting the expression levels of microRNA-150 and microRNA-886-3p in mammalian and human lung cancer and a method for detecting the expression levels of microRNA-150 and microRNA-886-3p in samples.
机译:本发明涉及两种微小RNA在检测肺癌预后和药物制备中的用途。特别地,本发明涉及包含两个小RNA分子microRNA-150和microRNA-886-3p的组合物,该装置包括用于检测肺癌预后和用于制备抑制哺乳动物和人肺癌转移的药物的组合物。具体地,microRNA-150和microRNA-886-3p的表达水平可以用作肺癌预后的预后标准,其中基因组合的高表达水平表明良好的治疗效果。本发明还涉及检测哺乳动物和人肺癌中的microRNA-150和microRNA-886-3p表达水平的装置,以及检测样品中的microRNA-150和microRNA-886-3p表达水平的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号